Selected Publications
McMahon CM; Ferng T; Canaani J; Wang ES; Morrissette JJD; Eastburn DJ; Pellegrino M; Durruthy-Durruthy R; Watt CD; Asthana S; Lasater EA; DeFilippis R; Peretz CAC; McGary LHF; Deihimi S; Logan AC; Luger SM; Shah NP; Carroll M; Smith CC; Perl AE.: Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia Cancer Discovery : 2020.
Foss, FM, Wang, XV, Luger, SM, Jegede, O, Miller, KB, Stadtmauer, EA, Whiteside, TL, Avigan, DE, Gascoyne, RD, Arber, D, Wagner, H, Strair, RK, Hogan, WJ, Sprague, KA, Lazarus, HM, Litzow, MR, Tallman, MS, Horning, SJ: Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902 Transfusion 60 (8): 1867-1872,2020.
Zeidan, AM, Boddu, PC, Patnaik, MM, Bewersdorf, JP, Stahl, M, Rampal, RK, Shallis, RM, Steensma, DP, Savona, MR, Sekeres, MA, Roboz, GJ, DeAngelo, DJ, Schuh, AC, Padron, E, Zeidner, JF, Walter, RB, Onida, F, Fathi, AT, DeZern, A, Hobbs, G, Stein, EM, Vyas, P, Wei, AH, Bowen, DT, Montesinos, P, Griffiths, EA, Verma, AK, Keyzner, A, Bar-Natan, M, Navada, SC, Kremyanskaya, M, Goldberg, AD, Al-Kali, A, Heaney, ML, Nazha, A, Salman, H, Luger, S, Pratz, KW, Konig, H, Komrokji, R, Deininger, M, Cirici, BX, Bhatt, VR, Silverman, LR, Erba, HP, Fenaux, P, Platzbecker, U, Santini, V, Wang, ES, Tallman, MS, Stone, RM, Mascarenhas, J: Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts Lancet Haematol. 7 (8): E601-E612,2020.
Kim GYG; Burns J; Freyer CW; Hamilton KW; Frey NV; Gill SI; Hexner EO; Luger SM; Mangan JK; Martin ME; McCurdy SR; Perl AE; Porter DL; Schuster MG; Stadtmauer EA; Loren AW.: Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents. Am J Hematol 95 : 792-798,2020.
Kim, GY, Burns, J, Freyer, CW, Hamilton, KW, Frey, NV, Gill, SI, Hexner, EO, Luger, SM, Mangan, JK, Martin, ME, McCurdy, SR, Perl, AE, Porter, DL, Schuster, MG, Stadtmauer, EA, Loren, AW: Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents Am J Hematol 95 (7): 792-798,2020.
Freyer, CW, Carulli, A, Ganetsky, A, Hughes, ME, Krause, TM, Timlin, C, Frey, NV, Gill, SI, Hexner, EO, Loren, AW, Mangan, JK, Martin, ME, McCurdy, SR, Perl, AE, Pratz, K, Porter, DL, Luger, SM: Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation Leukemia & Lymphoma 61 (9): 2200-2207,2020.
Pagel, JM, Othus, M, Garcia-Manero, G, Fang, M, Radich, JP, Rizzieri, DA, Marcucci, G, Strickland, SA, Litzow, MR, Savoie, ML, Spellman, SR, Confer, DL, Chell, JW, Brown, M, Medeiros, BC, Sekeres, MA, Lin, TL, Uy, GL, Powell, BL, Bayer, RL, Larson, RA, Stone, RM, Claxton, D, Essell, J, Luger, SM, Mohan, SR, Moseley, A, Erba, HP, Appelbaum, FR: Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia JCO Oncolocy Practice 16 (6): 331-+,2020.
Pine, AB, Chokr, N, Stahl, M, Steensma, DP, Sekeres, MA, Litzow, MR, Luger, SM, Stone, RM, Greenberg, PL, Bejar, R, Bewersdorf, JP, Gore, SD, Zeidan, AM: Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey Leukemia & Lymphoma 61 (6): 1455-1464,2020.
Shallis, RM, Stahl, M, Wei, W, Montesinos, P, Lengline, E, Neukirchen, J, Bhatt, VR, Sekeres, MA, Fathi, AT, Konig, H, Luger, S, Khan, I, Roboz, GJ, Cluzeau, T, Martinez-Cuadron, D, Raffoux, E, Germing, U, Umakanthan, JM, Mukhereje, S, Brunner, AM, Miller, A, McMahon, CM, Ritchie, EK, Rodriguez-Veiga, R, Itzykson, R, Boluda, B, Rabian, F, Tormo, M, Cruz, EA, Rabinovich, E, Yoo, B, Cano, I, Podoltsev, NA, Bewersdorf, JP, Gore, S, Zeidan, AM: Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy Leukemia & Lymphoma 61 (5): 1220-1225,2020.
Frey NV; Shaw PA; Hexner EO; Pequignot E; Gill S; Luger SM; Mangan JK; Loren AW; Perl AE; Maude SL; Grupp SA; Shah NN; Gilmore J; Lacey SF; Melenhorst JJ; Levine BL; June CH; Porter DL.: Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia J Clin Oncol 38 : 2020.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-157
34th and Civic Center Blvd
Philadelphia,
PA
19104
Phone: 215-614-1847
Patient appointments: 800-789-7366